Please read and agree to the
terms and conditions
of this site.
I agree
Funding Series
/tech
Clear filters and search
Format
photo
Tags
cancer
3
×
financing
funding
3
×
life sciences
national blog main
seattle blog main
3
×
antibody-drug conjugate
biotech
clinical trials
johnson & johnson
orbimed
seattle top stories
venture capital
abbvie
acerta pharma
adage capital management
adverse events
alexandria venture investments
antibody drugs
arix
arix bioscience
astrazeneca
bcma
biowa
bispecific antibodies
blood cancer
bristol meyers squibb
calistoga pharmaceuticals
car-t
celgene
cell therapy
citadel
clayton knox
colt ventures
cormorant asset management
dave johnson
decheng capital
drug conjugates
europe blog main
europe top stories
What
drug
3
×
cancer
targeting
years
adds
advance
advanced
anti
antibody
approval
avoid
based
bcma
biotech
cell
ceo
dangerous
dave
developing
diego
drugs
earns
effects
fda’s
glaxosmithkline
immunotherapies
johnson
kept
kipps
known
maturation
multiple
myeloma
nearly
new
nod
option
patients
physician
reseacher
Language
unset
Current search:
cancer
×
drug
×
" seattle blog main "
×
funding
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}